Xcyte Digital Corp.

XCYT

CA9839891046

Business Support Services

Market Closed - Toronto S.E. Other stock markets 11:44:26 2024-04-26 am EDT			5-day change	1st Jan Change
0.15 ^CAD	+7.14%		-11.76%	+25.00%

Apr. 03	Xcyte Digital Corp. acquired Assets of A+ Conferencing LLC for $0.5 million.	CI
Mar. 01	Xcyte Digital Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Xcyte Digital Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023

March 29, 2024 at 08:51 pm EST

Xcyte Digital Corp. reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported sales was USD 0.186149 million compared to USD 0.351675 million a year ago.

Revenue was USD 0.213572 million compared to USD 0.396759 million a year ago. Net loss was USD 2.95 million compared to USD 0.056135 million a year ago. Basic loss per share from continuing operations was USD 0.04.

Latest news about Xcyte Digital Corp.

Xcyte Digital Corp. acquired Assets of A+ Conferencing LLC for $0.5 million.	Apr. 02	CI
Xcyte Digital Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 29	CI
Xcyte Digital Corp. completed the acquisition of GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) from Noetic Psychedelic Fund LP, managed by Noetic Fund in a reverse merger transaction	Nov. 08	CI
Xcyte Digital Corporation announced that it has received CAD 4.467133 million in funding from GHP Noetic Science-Psychedelic Pharma Inc.	Nov. 08	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-17	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-30	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Xcyte Digital Corporation announced that it expects to receive CAD 4.2 million in funding from GHP Noetic Science-Psychedelic Pharma Inc.	23-02-08	CI
GHP Noetic Science-Psychedelic Pharma Inc. announced that it expects to receive CAD 4.2 million in funding	23-02-08	CI
Xcyte Digital Corp. signed a letter of intent to acquire GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) from Noetic Psychedelic Fund LP, managed by Noetic Fund in a reverse merger transaction for CAD 0.13 million.	23-02-08	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-11	CI
GHP Noetic Science-Psychedelic Pharma Inc. Announces Composition of Audit Committee	22-09-14	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-30	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-15	CI
GHP Noetic Science-Psychedelic Pharma Inc. and Diamond Therapeutics Announces Termination of Letter of Intent	22-05-03	CI
Diamond Therapeutics Inc. cancelled the acquisition of GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) in a reverse merger transaction.	22-05-02	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-01	CI
GHP Noetic Science-Psychedelic Pharma Inc. Announces Executive Changes	21-11-29	CI
GHP Noetic Science-Psychedelic Pharma Inc. Announces Resignation of Michael Maclachlan Franks as Director	21-11-29	CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-28	CI
Ghp Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-31	CI
Ghp Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-25	CI
Ghp Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Nine Months Ended December 31, 2020	21-04-30	CI
All Current Officers and Directors of GHP Noetic Science-Psychedelic Pharma Inc. to Resign	21-02-04	CI
Diamond Therapeutics Inc. signed of a letter of intent to acquire GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) for CAD 50.8 million in a reverse merger transaction.	21-02-03	CI

Chart Xcyte Digital Corp.

Duration

Period

More charts

Company Profile

Xcyte Digital Corp. is a Canada-based company. The Company is engaged in event technology aggregation and development and the provision of technology and support services to clients in order to facilitate virtual and hybrid events. The Companyâs solutions include virtual events, hybrid events, immersive solutions, event production, digital marketing, and lead generation. Its hybrid event services offer the ability to host live and pre-produced events. Its event-services team can create a customized experience to meet the needs of any events. Its comprehensive suite of metaverse services includes 3D world configuration, content management, digital asset creation, marketplace development, marketing, promotion, 3D commerce, extended reality, and community development. The Company provides a full suite of production capabilities, including custom staging, sound and lighting for video projection, recording systems, digital signage and interactive technologies.

Sector

Business Support Services

Calendar

2024-05-01 - Planet MicroCap Showcase

More about the company

Income Statement Evolution

More financial data

Sector Exhibition & Conference Services

	1st Jan change	Capi.
XCYTE DIGITAL CORP.	+25.00%	9.23M
INFORMA PLC	+2.51%	13.51B
VIAD CORP	-2.96%	739M
ZHEJIANG MEORIENT COMMERCE EXHIBITION INC.	-8.22%	714M
DLG EXHIBITIONS & EVENTS CORPORATION LIMITED	+1.24%	653M
GL EVENTS	-1.43%	604M
EMERALD HOLDING, INC.	-2.01%	370M
FIERA MILANO SPA	+39.24%	292M
BOLOGNAFIERE S.P.A.	0.00%	260M
PICO FAR EAST HOLDINGS LIMITED	+4.55%	255M

Exhibition & Conference Services